Regis Corporation
Get $10 bonus on your first $100 deposit for RGS
Get $10 bonus on your first $100 deposit for RGS
Regis Corporation (RGS) Stock Competitors & Peer Comparison
See (RGS) competitors and their performances in Stock Market.
Peer Comparison Table: Personal Products & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RGS | $27.09 | -1.56% | 68.5M | 0.61 | $44.99 | N/A |
| ROL | $56.99 | +3.02% | 27.5B | 52.29 | $1.09 | +1.22% |
| SCI | $86.37 | +2.06% | 12B | 22.73 | $3.80 | +1.54% |
| BFAM | $81.70 | -3.87% | 4.5B | 24.31 | $3.36 | N/A |
| FTDR | $60.91 | +0.59% | 4.3B | 17.82 | $3.42 | N/A |
| HRB | $31.01 | -1.49% | 3.9B | 7.25 | $4.28 | +5.25% |
| CVSA | $110.33 | -6.23% | 3.8B | 16.27 | $6.79 | N/A |
| DSEY | $8.40 | +0.06% | 2.7B | -14.47 | -$0.58 | N/A |
| MCW | $7.01 | +0.29% | 2.3B | 22.61 | $0.31 | N/A |
| ROVR | $11.00 | +0.05% | 2B | 183.25 | $0.06 | N/A |
Stock Comparison
RGS vs ROL Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, ROL has a market cap of 27.5B. Regarding current trading prices, RGS is priced at $27.09, while ROL trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas ROL's P/E ratio is 52.29. In terms of profitability, RGS's ROE is +0.71%, compared to ROL's ROE of +0.37%. Regarding short-term risk, RGS is less volatile compared to ROL. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check ROL's competition here
RGS vs SCI Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, SCI has a market cap of 12B. Regarding current trading prices, RGS is priced at $27.09, while SCI trades at $86.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas SCI's P/E ratio is 22.73. In terms of profitability, RGS's ROE is +0.71%, compared to SCI's ROE of +0.34%. Regarding short-term risk, RGS is more volatile compared to SCI. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check SCI's competition here
RGS vs BFAM Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, BFAM has a market cap of 4.5B. Regarding current trading prices, RGS is priced at $27.09, while BFAM trades at $81.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas BFAM's P/E ratio is 24.31. In terms of profitability, RGS's ROE is +0.71%, compared to BFAM's ROE of +0.14%. Regarding short-term risk, RGS is less volatile compared to BFAM. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check BFAM's competition here
RGS vs FTDR Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, FTDR has a market cap of 4.3B. Regarding current trading prices, RGS is priced at $27.09, while FTDR trades at $60.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas FTDR's P/E ratio is 17.82. In terms of profitability, RGS's ROE is +0.71%, compared to FTDR's ROE of +1.01%. Regarding short-term risk, RGS is less volatile compared to FTDR. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check FTDR's competition here
RGS vs HRB Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, HRB has a market cap of 3.9B. Regarding current trading prices, RGS is priced at $27.09, while HRB trades at $31.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas HRB's P/E ratio is 7.25. In terms of profitability, RGS's ROE is +0.71%, compared to HRB's ROE of -1.66%. Regarding short-term risk, RGS is less volatile compared to HRB. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check HRB's competition here
RGS vs CVSA Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, CVSA has a market cap of 3.8B. Regarding current trading prices, RGS is priced at $27.09, while CVSA trades at $110.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas CVSA's P/E ratio is 16.27. In terms of profitability, RGS's ROE is +0.71%, compared to CVSA's ROE of +0.18%. Regarding short-term risk, RGS is less volatile compared to CVSA. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check CVSA's competition here
RGS vs DSEY Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, DSEY has a market cap of 2.7B. Regarding current trading prices, RGS is priced at $27.09, while DSEY trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas DSEY's P/E ratio is -14.47. In terms of profitability, RGS's ROE is +0.71%, compared to DSEY's ROE of -0.23%. Regarding short-term risk, RGS is more volatile compared to DSEY. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check DSEY's competition here
RGS vs MCW Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, MCW has a market cap of 2.3B. Regarding current trading prices, RGS is priced at $27.09, while MCW trades at $7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas MCW's P/E ratio is 22.61. In terms of profitability, RGS's ROE is +0.71%, compared to MCW's ROE of +0.09%. Regarding short-term risk, RGS is more volatile compared to MCW. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check MCW's competition here
RGS vs ROVR Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, ROVR has a market cap of 2B. Regarding current trading prices, RGS is priced at $27.09, while ROVR trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas ROVR's P/E ratio is 183.25. In terms of profitability, RGS's ROE is +0.71%, compared to ROVR's ROE of -0.07%. Regarding short-term risk, RGS is more volatile compared to ROVR. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check ROVR's competition here
RGS vs CSV Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, CSV has a market cap of 802.4M. Regarding current trading prices, RGS is priced at $27.09, while CSV trades at $50.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas CSV's P/E ratio is 15.57. In terms of profitability, RGS's ROE is +0.71%, compared to CSV's ROE of +0.22%. Regarding short-term risk, RGS is less volatile compared to CSV. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check CSV's competition here
RGS vs EM Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, EM has a market cap of 148.4M. Regarding current trading prices, RGS is priced at $27.09, while EM trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas EM's P/E ratio is -117.00. In terms of profitability, RGS's ROE is +0.71%, compared to EM's ROE of -0.01%. Regarding short-term risk, RGS is more volatile compared to EM. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check EM's competition here
RGS vs MED Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, MED has a market cap of 121M. Regarding current trading prices, RGS is priced at $27.09, while MED trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas MED's P/E ratio is -6.45. In terms of profitability, RGS's ROE is +0.71%, compared to MED's ROE of -0.09%. Regarding short-term risk, RGS is more volatile compared to MED. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check MED's competition here
RGS vs WW Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, WW has a market cap of 92.9M. Regarding current trading prices, RGS is priced at $27.09, while WW trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas WW's P/E ratio is 1.23. In terms of profitability, RGS's ROE is +0.71%, compared to WW's ROE of -26.25%. Regarding short-term risk, RGS is less volatile compared to WW. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check WW's competition here
RGS vs XSPA Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, XSPA has a market cap of 54.5M. Regarding current trading prices, RGS is priced at $27.09, while XSPA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas XSPA's P/E ratio is 21.83. In terms of profitability, RGS's ROE is +0.71%, compared to XSPA's ROE of +35.63%. Regarding short-term risk, RGS is less volatile compared to XSPA. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check XSPA's competition here
RGS vs XWEL Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, XWEL has a market cap of 6.3M. Regarding current trading prices, RGS is priced at $27.09, while XWEL trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas XWEL's P/E ratio is -0.22. In terms of profitability, RGS's ROE is +0.71%, compared to XWEL's ROE of +1.77%. Regarding short-term risk, RGS is less volatile compared to XWEL. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check XWEL's competition here
RGS vs MRM Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, MRM has a market cap of 5.8M. Regarding current trading prices, RGS is priced at $27.09, while MRM trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas MRM's P/E ratio is 3.01. In terms of profitability, RGS's ROE is +0.71%, compared to MRM's ROE of +1.55%. Regarding short-term risk, RGS is less volatile compared to MRM. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check MRM's competition here
RGS vs EJH Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, EJH has a market cap of 5.2M. Regarding current trading prices, RGS is priced at $27.09, while EJH trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas EJH's P/E ratio is -0.02. In terms of profitability, RGS's ROE is +0.71%, compared to EJH's ROE of +0.01%. Regarding short-term risk, RGS is less volatile compared to EJH. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check EJH's competition here
RGS vs BYAH Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, BYAH has a market cap of 735K. Regarding current trading prices, RGS is priced at $27.09, while BYAH trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas BYAH's P/E ratio is N/A. In terms of profitability, RGS's ROE is +0.71%, compared to BYAH's ROE of -5.91%. Regarding short-term risk, RGS is less volatile compared to BYAH. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check BYAH's competition here
RGS vs TRNR Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, TRNR has a market cap of 147.9K. Regarding current trading prices, RGS is priced at $27.09, while TRNR trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas TRNR's P/E ratio is -0.01. In terms of profitability, RGS's ROE is +0.71%, compared to TRNR's ROE of -1.78%. Regarding short-term risk, RGS is less volatile compared to TRNR. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check TRNR's competition here
RGS vs IVP Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, IVP has a market cap of 85.8K. Regarding current trading prices, RGS is priced at $27.09, while IVP trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas IVP's P/E ratio is -0.00. In terms of profitability, RGS's ROE is +0.71%, compared to IVP's ROE of -5.20%. Regarding short-term risk, RGS is more volatile compared to IVP. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check IVP's competition here
RGS vs YYGH Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, YYGH has a market cap of 23K. Regarding current trading prices, RGS is priced at $27.09, while YYGH trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas YYGH's P/E ratio is N/A. In terms of profitability, RGS's ROE is +0.71%, compared to YYGH's ROE of -1.36%. Regarding short-term risk, RGS is less volatile compared to YYGH. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check YYGH's competition here
RGS vs TMX Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, TMX has a market cap of 0. Regarding current trading prices, RGS is priced at $27.09, while TMX trades at $37.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas TMX's P/E ratio is 70.13. In terms of profitability, RGS's ROE is +0.71%, compared to TMX's ROE of +0.05%. Regarding short-term risk, RGS is less volatile compared to TMX. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check TMX's competition here
RGS vs STON Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, STON has a market cap of 0. Regarding current trading prices, RGS is priced at $27.09, while STON trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas STON's P/E ratio is -6.64. In terms of profitability, RGS's ROE is +0.71%, compared to STON's ROE of +0.48%. Regarding short-term risk, RGS is more volatile compared to STON. This indicates potentially higher risk in terms of short-term price fluctuations for RGS.Check STON's competition here
RGS vs NEBCU Comparison April 2026
RGS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGS stands at 68.5M. In comparison, NEBCU has a market cap of 0. Regarding current trading prices, RGS is priced at $27.09, while NEBCU trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGS currently has a P/E ratio of 0.61, whereas NEBCU's P/E ratio is N/A. In terms of profitability, RGS's ROE is +0.71%, compared to NEBCU's ROE of -0.00%. Regarding short-term risk, RGS is less volatile compared to NEBCU. This indicates potentially lower risk in terms of short-term price fluctuations for RGS.Check NEBCU's competition here